{"id":446,"date":"2019-03-14T11:57:09","date_gmt":"2019-03-14T10:57:09","guid":{"rendered":"http:\/\/www.mammaprint.cz\/blueprint\/"},"modified":"2019-03-14T12:36:30","modified_gmt":"2019-03-14T11:36:30","slug":"blueprint","status":"publish","type":"page","link":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/","title":{"rendered":"BluePrint"},"content":{"rendered":"<p>[et_pb_section bb_built=&#8221;1&#8243; _builder_version=&#8221;3.0.47&#8243; custom_padding=&#8221;54px|0px|22px|0px|false|false&#8221; next_background_color=&#8221;#000000&#8243;][et_pb_row _builder_version=&#8221;3.0.48&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;1_3&#8243;][et_pb_image src=&#8221;http:\/\/www.mammaprint.cz\/wp-content\/uploads\/2019\/01\/Agendia_BluePrint_Logo-1.jpg&#8221; align=&#8221;center&#8221; _builder_version=&#8221;3.19.4&#8243; max_width=&#8221;75%&#8221; module_alignment=&#8221;center&#8221; \/][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243;][et_pb_text _builder_version=&#8221;3.19.4&#8243; text_font_size=&#8221;16px&#8221; text_line_height=&#8221;1.8em&#8221;]<\/p>\n<h2><strong>\u010co je BluePrint?<\/strong><\/h2>\n<p>BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov:<\/p>\n<ul>\n<li>Lumin\u00e1lny<\/li>\n<li>HER2<\/li>\n<li>Baz\u00e1lny.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; specialty=&#8221;off&#8221; prev_background_color=&#8221;#ffffff&#8221; next_background_color=&#8221;#ffffff&#8221; _builder_version=&#8221;3.19.4&#8243; use_background_color_gradient=&#8221;on&#8221; background_color_gradient_start=&#8221;#094fa4&#8243; background_color_gradient_end=&#8221;#16c1f4&#8243; background_color_gradient_direction=&#8221;70deg&#8221;][et_pb_row _builder_version=&#8221;3.19.4&#8243; module_alignment=&#8221;center&#8221; make_equal=&#8221;on&#8221;][et_pb_column type=&#8221;1_3&#8243;][et_pb_number_counter _builder_version=&#8221;3.19.4&#8243; number=&#8221;21&#8243; background_layout=&#8221;dark&#8221; title_level=&#8221;h4&#8243; title_font=&#8221;|700|||||||&#8221; number_text_color=&#8221;#ffffff&#8221; number_font=&#8221;|700|||||||&#8221; number_font_size=&#8221;100&#8243; title_font_size=&#8221;20&#8243; animation_style=&#8221;fade&#8221; custom_margin=&#8221;45px|||&#8221; \/][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243;][et_pb_text _builder_version=&#8221;3.19.4&#8243; text_text_color=&#8221;#ffffff&#8221; text_font_size=&#8221;19px&#8221;]<\/p>\n<p>V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami MammaPrint a BluePrint ku spresneniu predpovede progn\u00f3zy pacienta a pomoci pri v\u00fdbere vhodnej lie\u010dby. 21% pacientov bolo preklasifikovan\u00fdch ako MAmmaPrint n\u00edzkorizikov\u00fdch, BluePrint lumin\u00e1lny typA  a uk\u00e1zali tak mal\u00fd, pokia\u013e v\u00f4bec nejak\u00fd efekt chemoterapie pre pacientov.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section bb_built=&#8221;1&#8243; _builder_version=&#8221;3.0.47&#8243; custom_padding=&#8221;12px|0px|54px|0px|false|false&#8221; prev_background_color=&#8221;#000000&#8243;][et_pb_row _builder_version=&#8221;3.0.48&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_text _builder_version=&#8221;3.19.4&#8243;]<\/p>\n<p>V kombin\u00e1cii s MammaPrint m\u00f4\u017eu by\u0165 pacientky zaraden\u00e9 do nasleduj\u00facich \u0161tyroch podtypov:<\/p>\n<ul>\n<li>Lumin\u00e1lny\/s n\u00edzkym rizikom (lumin\u00e1lny A)<\/li>\n<li>Lumin\u00e1lny\/s vysok\u00fdm rizikom (lumin\u00e1lny B)<\/li>\n<li>HER2<\/li>\n<li>Baz\u00e1lny<\/li>\n<\/ul>\n<p><strong>Ako prebieha testovanie?? <\/strong><\/p>\n<p>Testy MammaPrint a BluePrint je mo\u017en\u00e9 vykona\u0165 naraz a na jednej vzorke tkaniva. V\u00fdsledky s\u00fa k dispoz\u00edcii do desiatich dn\u00ed.<\/p>\n<p><strong>Komu je BluePrint ur\u010den\u00fd?<\/strong><\/p>\n<p>Obidva testy, MammaPrint aj BluePrint s\u00fa navrhnut\u00e9 pre \u017eeny v\u0161etk\u00fdch vekov\u00fdch kateg\u00f3ri\u00ed, ktor\u00e9:<\/p>\n<ul>\n<li>S\u00fa novo diagnostikovan\u00e9 s invaz\u00edvnym karcin\u00f3mom prsn\u00edka v po\u010diato\u010dnom \u0161t\u00e1diu (\u0161t\u00e1dium I alebo II)<\/li>\n<li>Maj\u00fa negat\u00edvne lymfatick\u00e9 uzliny alebo 1-3 pozit\u00edvne lymfatick\u00e9 uzliny<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u010co je BluePrint? BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov: Lumin\u00e1lny HER2 Baz\u00e1lny. V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami MammaPrint [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-446","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"\u010co je BluePrint? BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov: Lumin\u00e1lny HER2 Baz\u00e1lny. % V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.mammaprint.cz\/sk\/blueprint\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"sk_SK\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Mammaprint - Genomick\u00fd test rizika rekurence, kter\u00fd pom\u00e1h\u00e1 pacientk\u00e1m a l\u00e9ka\u0159\u016fm d\u011blat jednozna\u010dn\u00e1 rozhodnut\u00ed t\u00fdkaj\u00edc\u00ed se l\u00e9\u010dby \u010dasn\u00e9ho karcinomu prsu.\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"BluePrint - Mammaprint\" \/>\n\t\t<meta property=\"og:description\" content=\"\u010co je BluePrint? BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov: Lumin\u00e1lny HER2 Baz\u00e1lny. % V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.mammaprint.cz\/sk\/blueprint\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2019-03-14T10:57:09+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2019-03-14T11:36:30+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"BluePrint - Mammaprint\" \/>\n\t\t<meta name=\"twitter:description\" content=\"\u010co je BluePrint? BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov: Lumin\u00e1lny HER2 Baz\u00e1lny. % V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/blueprint\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/blueprint\\\/#listItem\",\"name\":\"BluePrint\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/blueprint\\\/#listItem\",\"position\":2,\"name\":\"BluePrint\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/#organization\",\"name\":\"LERAM diagnostic s.r.o.\",\"description\":\"Genomick\\u00fd test rizika rekurence, kter\\u00fd pom\\u00e1h\\u00e1 pacientk\\u00e1m a l\\u00e9ka\\u0159\\u016fm d\\u011blat jednozna\\u010dn\\u00e1 rozhodnut\\u00ed t\\u00fdkaj\\u00edc\\u00ed se l\\u00e9\\u010dby \\u010dasn\\u00e9ho karcinomu prsu.\",\"url\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/blueprint\\\/#webpage\",\"url\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/blueprint\\\/\",\"name\":\"BluePrint - Mammaprint\",\"description\":\"\\u010co je BluePrint? BluePrint je genomick\\u00fd test, ktor\\u00fd vie predv\\u00edda\\u0165 pravdepodobn\\u00e9 spr\\u00e1vanie sa n\\u00e1doru na z\\u00e1klade anal\\u00fdzy aktivity 80 g\\u00e9nov a umo\\u017e\\u0148uje tak stratifik\\u00e1ciu n\\u00e1doru do jedn\\u00e9ho z troch nasleduj\\u00facich podtypov: Lumin\\u00e1lny HER2 Baz\\u00e1lny. % V\\u00fdsledky \\u0161t\\u00fadie z roku 2013 preuk\\u00e1zali, \\u017ee oproti tradi\\u010dn\\u00fdm histopatologick\\u00fdm met\\u00f3dam ak\\u00fdmi s\\u00fa IHC a FISH, vedie spolo\\u010dn\\u00e9 testovanie testami\",\"inLanguage\":\"sk-SK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/blueprint\\\/#breadcrumblist\"},\"datePublished\":\"2019-03-14T11:57:09+01:00\",\"dateModified\":\"2019-03-14T12:36:30+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/#website\",\"url\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/\",\"name\":\"Mammaprint\",\"description\":\"Genomick\\u00fd test rizika rekurence, kter\\u00fd pom\\u00e1h\\u00e1 pacientk\\u00e1m a l\\u00e9ka\\u0159\\u016fm d\\u011blat jednozna\\u010dn\\u00e1 rozhodnut\\u00ed t\\u00fdkaj\\u00edc\\u00ed se l\\u00e9\\u010dby \\u010dasn\\u00e9ho karcinomu prsu.\",\"inLanguage\":\"sk-SK\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mammaprint.cz\\\/sk\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"BluePrint - Mammaprint","description":"\u010co je BluePrint? BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov: Lumin\u00e1lny HER2 Baz\u00e1lny. % V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami","canonical_url":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.mammaprint.cz\/sk\/#listItem","position":1,"name":"Home","item":"https:\/\/www.mammaprint.cz\/sk\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/#listItem","name":"BluePrint"}},{"@type":"ListItem","@id":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/#listItem","position":2,"name":"BluePrint","previousItem":{"@type":"ListItem","@id":"https:\/\/www.mammaprint.cz\/sk\/#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/www.mammaprint.cz\/sk\/#organization","name":"LERAM diagnostic s.r.o.","description":"Genomick\u00fd test rizika rekurence, kter\u00fd pom\u00e1h\u00e1 pacientk\u00e1m a l\u00e9ka\u0159\u016fm d\u011blat jednozna\u010dn\u00e1 rozhodnut\u00ed t\u00fdkaj\u00edc\u00ed se l\u00e9\u010dby \u010dasn\u00e9ho karcinomu prsu.","url":"https:\/\/www.mammaprint.cz\/sk\/"},{"@type":"WebPage","@id":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/#webpage","url":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/","name":"BluePrint - Mammaprint","description":"\u010co je BluePrint? BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov: Lumin\u00e1lny HER2 Baz\u00e1lny. % V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami","inLanguage":"sk-SK","isPartOf":{"@id":"https:\/\/www.mammaprint.cz\/sk\/#website"},"breadcrumb":{"@id":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/#breadcrumblist"},"datePublished":"2019-03-14T11:57:09+01:00","dateModified":"2019-03-14T12:36:30+01:00"},{"@type":"WebSite","@id":"https:\/\/www.mammaprint.cz\/sk\/#website","url":"https:\/\/www.mammaprint.cz\/sk\/","name":"Mammaprint","description":"Genomick\u00fd test rizika rekurence, kter\u00fd pom\u00e1h\u00e1 pacientk\u00e1m a l\u00e9ka\u0159\u016fm d\u011blat jednozna\u010dn\u00e1 rozhodnut\u00ed t\u00fdkaj\u00edc\u00ed se l\u00e9\u010dby \u010dasn\u00e9ho karcinomu prsu.","inLanguage":"sk-SK","publisher":{"@id":"https:\/\/www.mammaprint.cz\/sk\/#organization"}}]},"og:locale":"sk_SK","og:site_name":"Mammaprint - Genomick\u00fd test rizika rekurence, kter\u00fd pom\u00e1h\u00e1 pacientk\u00e1m a l\u00e9ka\u0159\u016fm d\u011blat jednozna\u010dn\u00e1 rozhodnut\u00ed t\u00fdkaj\u00edc\u00ed se l\u00e9\u010dby \u010dasn\u00e9ho karcinomu prsu.","og:type":"article","og:title":"BluePrint - Mammaprint","og:description":"\u010co je BluePrint? BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov: Lumin\u00e1lny HER2 Baz\u00e1lny. % V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami","og:url":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/","article:published_time":"2019-03-14T10:57:09+00:00","article:modified_time":"2019-03-14T11:36:30+00:00","twitter:card":"summary_large_image","twitter:title":"BluePrint - Mammaprint","twitter:description":"\u010co je BluePrint? BluePrint je genomick\u00fd test, ktor\u00fd vie predv\u00edda\u0165 pravdepodobn\u00e9 spr\u00e1vanie sa n\u00e1doru na z\u00e1klade anal\u00fdzy aktivity 80 g\u00e9nov a umo\u017e\u0148uje tak stratifik\u00e1ciu n\u00e1doru do jedn\u00e9ho z troch nasleduj\u00facich podtypov: Lumin\u00e1lny HER2 Baz\u00e1lny. % V\u00fdsledky \u0161t\u00fadie z roku 2013 preuk\u00e1zali, \u017ee oproti tradi\u010dn\u00fdm histopatologick\u00fdm met\u00f3dam ak\u00fdmi s\u00fa IHC a FISH, vedie spolo\u010dn\u00e9 testovanie testami"},"aioseo_meta_data":{"post_id":"446","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"created":"2023-06-30 13:35:00","updated":"2026-08-09 09:52:37","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.mammaprint.cz\/sk\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tBluePrint\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.mammaprint.cz\/sk\/"},{"label":"BluePrint","link":"https:\/\/www.mammaprint.cz\/sk\/blueprint\/"}],"_links":{"self":[{"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/pages\/446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/comments?post=446"}],"version-history":[{"count":3,"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/pages\/446\/revisions"}],"predecessor-version":[{"id":472,"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/pages\/446\/revisions\/472"}],"wp:attachment":[{"href":"https:\/\/www.mammaprint.cz\/sk\/wp-json\/wp\/v2\/media?parent=446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}